Plain-English translation of NCT06096870 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing , a medication that blocks male hormones that fuel prostate cancer growth. Researchers want to see if works better when combined with another new treatment called , which helps the immune system fight cancer. The trial includes men whose prostate cancer has come back and shows up on special PET imaging scans.
Current hormone-blocking treatments for recurring prostate cancer often require additional medications to suppress testosterone, which can cause uncomfortable side effects. This trial is exploring whether the medication can be effective on its own or in combination with an immune-boosting therapy, potentially offering patients a simpler treatment with fewer side effects while still controlling their cancer for months to years.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth, likely for several months as an outpatient. You'll have regular visits with the research team to check your health through blood tests and imaging scans (including PET scans) to see how the treatment is working. The exact schedule will depend on which group you're randomly assigned to—some participants will take alone, while others will receive a combination of both medications. Your doctor will monitor you closely for any side effects and to track whether your PSA levels and cancer are responding to treatment.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States